Connection
James Burton to Drug Monitoring
This is a "connection" page, showing publications James Burton has written about Drug Monitoring.
|
|
Connection Strength |
|
 |
|
 |
|
0.013 |
|
|
|
-
Alexander JH, Dyke CK, Yang H, Becker RC, Hasselblad V, Zillman LA, Kleiman NS, Hochman JS, Berger PB, Cohen EA, Lincoff AM, Saint-Jacques H, Chetcuti S, Burton JR, Buergler JM, Spence FP, Shimoto Y, Robertson TL, Kunitada S, Bovill EG, Armstrong PW, Harrington RA. Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot. J Thromb Haemost. 2004 Feb; 2(2):234-41.
Score: 0.013